Cargando…

Current landscape of clinical trials for HPV-positive head and neck squamous cell carcinoma (HNSCC)

This study aims to determine the current state of clinical trials regarding HPV-positive head and neck squamous cell carcinoma (HNSCC). Clinical trials were filtered to fit the study’s aim using Clinicaltrials.gov: trials concerning HNSCC specifically those related to HPV done between January 2005 a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bteich, Yara T, Hosri, Jad E, Wehbi, Jad A, Daou, Lea R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cancer Intelligence 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666285/ https://www.ncbi.nlm.nih.gov/pubmed/36405940 http://dx.doi.org/10.3332/ecancer.2022.1447

Ejemplares similares

COVID-19 and Liver Dysfunction
por: Ibrahim, Nour, et al.
Publicado: (2022)

Radioimmunotherapy of experimental head and neck squamous cell carcinoma (HNSCC) with E6-specific antibody using a novel HPV-16 positive HNSCC cell line
por: Harris, Matthew, et al.
Publicado: (2011)

Immunotherapeutic Strategies for Head and Neck Squamous Cell Carcinoma (HNSCC): Current Perspectives and Future Prospects
por: Gao, Lei, et al.
Publicado: (2022)

Differential expression profiling of head and neck squamous cell carcinoma (HNSCC)
por: Lemaire, F, et al.
Publicado: (2003)

Radiosensitization approaches for HPV‐positive and HPV‐negative head and neck squamous carcinomas
por: Dok, Rüveyda, et al.
Publicado: (2019)

The radiobiology of HPV-positive and HPV-negative head and neck squamous cell carcinoma
por: Zhou, Chumin, et al.
Publicado: (2020)

Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC)
por: Dayyani, Farshid, et al.
Publicado: (2010)

Comprehensive Genomic Review of TCGA Head and Neck Squamous Cell Carcinomas (HNSCC)
por: Pérez Sayáns, Mario, et al.
Publicado: (2019)

MicroRNAs in Head and Neck Squamous Cell Carcinoma (HNSCC) and Oral Squamous Cell Carcinoma (OSCC)
por: Shiiba, Masashi, et al.
Publicado: (2010)

The roles of HOXD10 in the development and progression of head and neck squamous cell carcinoma (HNSCC)
por: Hakami, F, et al.
Publicado: (2014)

Diagnostic Tumor Markers in Head and Neck Squamous Cell Carcinoma (HNSCC) in the Clinical Setting
por: Economopoulou, Panagiota, et al.
Publicado: (2019)

Predictive models for stage and risk classification in head and neck squamous cell carcinoma (HNSCC)
por: Kumar, Sugandh, et al.
Publicado: (2020)

MUC1 confers radioresistance in head and neck squamous cell carcinoma (HNSCC) cells
por: Huang, Tian-qiao, et al.
Publicado: (2020)

Markers of Epithelial to Mesenchymal Transition in Association with Survival in Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Pectasides, Eirini, et al.
Publicado: (2014)

Pretreatment oral hygiene habits and survival of head and neck squamous cell carcinoma (HNSCC) patients
por: Friemel, Juliane, et al.
Publicado: (2016)

Detection of Circulating Tumor Cell Subpopulations in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Weller, Patrick, et al.
Publicado: (2014)

Quercetin suppresses cellular migration and invasion in human head and neck squamous cell carcinoma (HNSCC)
por: Chan, Chien-Yi, et al.
Publicado: (2016)

Molecular Response to Combined Molecular- and External Radiotherapy in Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Rassamegevanon, Treewut, et al.
Publicado: (2021)

Head and Neck Squamous Cell Carcinoma Vaccine: Current Landscape and Perspectives
por: Meliante, Piero Giuseppe, et al.
Publicado: (2023)

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)
por: Cohen, Ezra E. W., et al.
Publicado: (2019)

Targeting phosphoinositide 3-kinase (PI3K) in head and neck squamous cell carcinoma (HNSCC)
por: Jung, Kyungsuk, et al.
Publicado: (2018)

Over-expression of BAG-1 in head and neck squamous cell carcinomas (HNSCC) is associated with cisplatin-resistance
por: Liu, Shutong, et al.
Publicado: (2017)

SATB1 as oncogenic driver and potential therapeutic target in head & neck squamous cell carcinoma (HNSCC)
por: Panchal, Omkar, et al.
Publicado: (2020)

Establishment of anti-DKK3 peptide for the cancer control in head and neck squamous cell carcinoma (HNSCC)
por: Katase, Naoki, et al.
Publicado: (2022)

Clinicopathological Parameters and Biomarker Profile in a Cohort of Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Hashmi, Atif A, et al.
Publicado: (2023)

Role of circulating tumour cells (CTCs) in recurrent/metastatic head and neck squamous cell carcinoma (HNSCC)
por: Baa, Annie Kanchan, et al.
Publicado: (2023)

Oncolytic activity of reovirus in HPV positive and negative head and neck squamous cell carcinoma
por: Cooper, Timothy, et al.
Publicado: (2015)

Unique DNA methylation signature in HPV-positive head and neck squamous cell carcinomas
por: Degli Esposti, Davide, et al.
Publicado: (2017)

FDCSP Is an Immune-Associated Prognostic Biomarker in HPV-Positive Head and Neck Squamous Carcinoma
por: Wu, Qingqing, et al.
Publicado: (2022)

Oral-genital HPV infection transmission, concordance of HPV genotypes and genital lesions among spouses/ partners of patients diagnosed with HPV-related head and neck squamous cell carcinoma (HNSCC): a scoping review
por: Kalinganire, Nadia, et al.
Publicado: (2023)

In vitro effects of gamma-secretase inhibition in HPV-positive and HPV-negative head and neck squamous cell carcinoma
por: Varatanovic, Sara, et al.
Publicado: (2023)

Radioimmunotherapy in HPV-Associated Head and Neck Squamous Cell Carcinoma
por: Zhou, Xin, et al.
Publicado: (2022)

β-CATENIN is a positive prognostic marker for HPV-positive head and neck squamous cell carcinoma
por: Stoiber, Stefan, et al.
Publicado: (2023)

Amplification of Cyclin L1 is associated with lymph node metastases in head and neck squamous cell carcinoma (HNSCC)
por: Sticht, C, et al.
Publicado: (2005)

Establishment and Molecular Cytogenetic Characterization of a Cell Culture Model of Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Bauer, Verena L., et al.
Publicado: (2010)

Rac1 as a potential therapeutic target for chemo-radioresistant head and neck squamous cell carcinomas (HNSCC)
por: Skvortsov, S, et al.
Publicado: (2014)

The α2-HeremansSchmid glycoprotein (AHSG) promotes growth in head and neck squamous cell carcinoma (HNSCC)
por: Thompson, Pamela D, et al.
Publicado: (2013)

A three-lncRNA expression signature predicts survival in head and neck squamous cell carcinoma (HNSCC)
por: Wang, Peng, et al.
Publicado: (2018)

Diagnostic and Therapeutic Applications of Exosomes in Cancer with a Special Focus on Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Ebnoether, Eliane, et al.
Publicado: (2020)

Prognostic Value of MiR-21: An Updated Meta-Analysis in Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Irimie-Aghiorghiesei, Alexandra Iulia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_b9jkpsh073l4u6b92clai31h23